Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.86) per share. This is a 79.18 percent increase over losses of $(4.13) per share from the same period last year.
Senti Biosciences Q2 EPS $(0.86) Up From $(4.13) YoY
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.86) per share. This is a 79.18 percent increase over losses of $(4.13) per share from the same period last year.
Related Posts
Linde Announces Sanjiv Lamba As New CEO; Current CEO Steve Angel To Succeed Wolfgang Reitzle As Chairman Of Board
Today, 6:37 AM
Linde (NYSE:LIN); (FWB:LIN) today announced its Board of Directors has appointed Sanjiv Lamba to succeed Steve Angel as Chief Executive Officer and Steve Angel to succeed Wolfgang Reitzle as Chairman, effective March 1,
Alphabet CFO Says No Plans To Do Stock Split Because Fractional Shares Can Be Purchased
Today, 6:37 AM
-Reuters Citing Meeting
Aurora Mobile: Q2 Earnings Insights
Today, 6:37 AM
Aurora Mobile (NASDAQ:JG) reported its Q2 earnings results on Thursday, September 15, 2022 at 03:30 AM.
Here's what investors need to know about the announcement.